Chiral Iron Oxide Supraparticles Enable Enantiomer‐dependent Tumor‐Targeted Magnetic Resonance Imaging

Chen Li,Jing Zhao,Xiaoqing Gao,Changlong Hao,Shudong Hu,Aihua Qu,Maozhong Sun,Hua Kuang,Chuanlai Xu,Liguang Xu
DOI: https://doi.org/10.1002/adma.202308198
IF: 29.4
2023-09-20
Advanced Materials
Abstract:The chemical, physical and biological effects of chiral nanomaterials have inspired general interest and demonstrated the important advantages in fundamental science. Here, we fabricated chiral iron oxide supraparticles (Fe3O4 SPs) modified by chiral penicillamine (Pen) molecules with a g‐factor of approximately 2 × 10−3 at 415 nm, these SPs acted as a high‐quality magnetic resonance imaging (MRI) contrast agent. Therein, the transverse relaxation efficiency and T2‐MRI results demonstrated the chiral Fe3O4 SPs had a r2 relaxivity of 157.39 ± 2.34 mM−1·S−1 for D‐Fe3O4 SPs and 136.21 ± 1.26 mM−1·S−1 for L‐Fe3O4 SPs due to the enhanced electronic transition dipole moment for D‐Fe3O4 SPs compared with L‐Fe3O4 SPs. The in vivo MRI results showed that D‐Fe3O4 SPs exhibited a two‐fold lower contrast ratio than L‐Fe3O4 SPs, which enhanced targeted enrichment in tumor tissue, such as prostate cancer, melanoma, and brain glioma tumor. Notably, it w as found that D‐Fe3O4 SPs had a 7.7‐fold higher affinity for the tumor cell surface receptor cluster‐of‐differentiation 47 (CD47) than L‐Fe3O4 SPs. These findings uncovered that chiral Fe3O4 SPs act as a highly effective MRI contrast agent for targeting and imaging broad tumors, thus accelerating the practical application of chiral nanomaterials and deepening the understanding of chirality in the biological and non‐biological environments. This article is protected by copyright. All rights reserved
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?